| CVVH (n= 35) | CVVHD (n= 38) | P-value |
---|---|---|---|
Duration RRT prescribed, hrs | 146 ± 240 | 145 ± 156 | 0.88 |
Duration RRT received, hrs | 130 ± 222 | 128 ± 142 | 0.87 |
Mean pre-filter replacement solution flow, mL/hr | 1533 ± 442 | 0 | n/a |
Mean post-filter replacement solution flow, mL/hr | 1440 ± 488 | 180 ± 140 | n/a |
Mean dialysate flow, mL/hr | 0 | 2871 ± 872 | n/a |
Mean RRT dose, mL/kg/hr | 33.6 ± 7.4 | 34.7 ± 4.4 | 0.50 |
Prescribed dose delivered, % | 84.7 ± 16.3 | 87.8 ± 13.7 | 0.73 |
Net ultrafiltration, L/day | 1.7 ± 2.2 | 0.8 ± 4.1 | 0.98 |
Days on study therapy | 5 (3-7) | 4.50 (3.00-10.25) | 0.79 |
Primary reason for CRRT withdrawal | Â | Â | 0.75 |
Death while on CRRT | 12 (35%) | 10 (27%) | Â |
Kidney function recovery | 7 (21%) | 7 (19%) | Â |
Transfer to intermittent hemodialysis | 12 (35%) | 14 (38%) | Â |
Withdrawal of life support | 3 (9%) | 6 (16%) | Â |
Catheter changes/day of therapy | 0.09 ± 0.2 | 0.1 ± 0.2 | 0.92 |
Units RBCs transfused/day of therapy | 0.3 ± 0.3 | 0.4 ± 0.7 | 0.38 |
Unscheduled circuit changes/day of therapy | 0.2 ± 0.3 | 0.2 ± 0.2 | 0.36 |
Study days with receipt of norepinephrine, % | 61.8 ± 36.2 | 65.7 ± 7.5 | 0.41 |
Study days with receipt of vasopressin, % | 35.4 ± 35.9 | 43.0 ± 43.6 | 0.51 |